Repligen Corp reports results for the quarter ended September 30 - Earnings Summary

Repligen

12/11/2024 15:27

* Repligen Corp  RGEN.OQ  reported quarterly adjusted
earnings of
43 cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of 23 cents.  The mean expectation of fifteen analysts for the
quarter was for earnings of 33 cents per share. Wall Street
expected results to range from 28 cents to 39 cents per share.
    * Revenue rose 9.7% to $154.83 million from a year ago;
analysts
expected $153.23 million. 
    * Repligen Corp's reported EPS for the quarter was a loss of
1
cent​.
    * The company reported a quarterly loss of $653 thousand.
    * Repligen Corp shares had fallen by 6.3% this quarter and
lost 22.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Repligen Corp is
190.00 
This summary was machine generated from LSEG data November 12 at
03:27 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.33           0.43           Beat
 Jun. 30 2024      0.33           0.33           Met
 Mar. 31 2024      0.30           0.28           Missed
 Dec. 31 2023      0.33           0.33           Met